Apatinib Monotherapy as a Second-Line Treatment for Patients with Advanced Biliary Tract Cancer: a Retrospective Single-Center Observational Study

Journal of Cancer Research and Therapeutic Oncology Pub Date : 2019-01-01 DOI:10.17303/jcrto.2019.7.205

Yue Zhao, W. Gu, Jianmei Li, C. Tian

引用次数: 0

Abstract

Apatinib Monotherapy as a Second-Line Treatment for Patients with Advanced Biliary Tract Cancer: a Retrospective Single-Center Observational Study Yue Zhao1, #,*, Wenqian Gu2, #, Jianmei Li1, Chunyuan Tian1 1Department of Oncology, Qinhuangdao Fourth Hospital, 64 Guangming Rd, 066000, Hebei Province, China 2Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 165, 8200 Aarhus N, Denmark Research Open Access Journal of Cancer Research and Therapeutic Oncology

查看原文本刊更多论文

阿帕替尼单药治疗作为晚期胆道癌患者的二线治疗:一项回顾性单中心观察研究

阿帕提尼单药治疗晚期胆道肿瘤的二线疗效:回顾性单中心观察研究赵岳1，#，*，古文倩2，#，李建梅1，田春元1秦皇岛第四医院肿瘤科，河北光明路64号，066000;2奥胡斯大学临床医学系，Palle juul - jensen大道165号，8200丹麦奥胡斯大学肿瘤研究与治疗肿瘤学研究开放获得期刊

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cancer Research and Therapeutic Oncology

自引率

0.00%

发文量